Evaluation of the Switch From Amiodarone to Dronedarone in Patients With Atrial Fibrillation: Results of the ARTEMIS AF Studies.

Gerald V NaccarelliDeepak L BhattA John CammJean-Yves Le HeuzeyFederico LombardiJuan TamargoJean-Marie MartinezLisa Naditch-Brûlénull null

Published in: Journal of cardiovascular pharmacology and therapeutics (2020)

The trial was terminated early due to poor recruitment and so our findings are limited by low numbers. However, immediate switching from amiodarone to dronedarone appeared to be well tolerated and safe.

Keyphrases

study protocol
phase iii
atrial fibrillation
clinical trial
phase ii
case control
randomized controlled trial